Table 2 Clinical characteristics of patients including in the study and follow-up
Clinical manifestations | Baseline (n = 29) | After 12 months (n = 28) | After 24 months (n = 28) | p value |
|---|---|---|---|---|
Pain (%) | 12/29 (47.7) | 10/28 (37.7) | 9/28 (32.1) | 0.4699 |
Fatigue (%) | 7/26 (26.9) | 5/26 (19.2) | 5/26 (19.2) | 0.6145 |
Spleen enlargement* (range in cm) | 10/23 (12–22) | 10/24 (12–20) | 5/16 (12–20) | – |